NCT04529538: Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines |
|
|
| Completed | 1 | 226 | US | Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1), Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3), Sabin monovalent oral polio vaccine type 3 | PATH, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention, Viroclinics Biosciences B.V., The Emmes Company, LLC | Poliomyelitis | 02/23 | 02/23 | | |
